- Home
- CPRX vs CC Comparison
CPRX vs CC Comparison
Compare CPRX & CC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CPRX
- CC
- Stock Information
- Founded
- CPRX 2002
- CC 2014
- Country
- CPRX United States
- CC United States
- Employees
- CPRX N/A
- CC N/A
- Industry
- CPRX Biotechnology: Pharmaceutical Preparations
- CC Major Chemicals
- Sector
- CPRX Health Care
- CC Industrials
- Exchange
- CPRX Nasdaq
- CC Nasdaq
- Market Cap
- CPRX 2.6B
- CC 2.3B
- IPO Year
- CPRX 2006
- CC N/A
- Fundamental
- Price
- CPRX $20.82
- CC $15.08
- Analyst Decision
- CPRX Strong Buy
- CC Buy
- Analyst Count
- CPRX 5
- CC 8
- Target Price
- CPRX $33.20
- CC $18.13
- AVG Volume (30 Days)
- CPRX 1.6M
- CC 2.9M
- Earning Date
- CPRX 11-05-2025
- CC 11-03-2025
- Dividend Yield
- CPRX N/A
- CC 2.32%
- EPS Growth
- CPRX 183.96
- CC N/A
- EPS
- CPRX 1.65
- CC N/A
- Revenue
- CPRX $558,499,000.00
- CC $5,850,000,000.00
- Revenue This Year
- CPRX $16.51
- CC $4.91
- Revenue Next Year
- CPRX $9.58
- CC $4.73
- P/E Ratio
- CPRX $12.64
- CC N/A
- Revenue Growth
- CPRX 28.55
- CC 0.62
- 52 Week Low
- CPRX $19.05
- CC $9.13
- 52 Week High
- CPRX $26.58
- CC $22.38
- Technical
- Relative Strength Index (RSI)
- CPRX 58.08
- CC 43.26
- Support Level
- CPRX $19.05
- CC $15.25
- Resistance Level
- CPRX $21.07
- CC $16.41
- Average True Range (ATR)
- CPRX 0.59
- CC 0.77
- MACD
- CPRX 0.16
- CC -0.30
- Stochastic Oscillator
- CPRX 60.27
- CC 7.28
About CPRX Catalyst Pharmaceuticals Inc.
Catalyst Pharmaceuticals Inc is a biopharmaceutical company. It focuses on developing and commercializing, developing therapies for people with rare, debilitating, chronic neuromuscular and neurological diseases. It offers three drug products, FIRDAPSE (amifampridine), FYCOMPA (perampanel), and AGAMREE (vamorolone).
About CC Chemours Company (The)
The Chemours Co is a provider of chemicals. It delivers customized solutions with a wide range of industrial and specialty chemicals products for various markets including coatings, plastics, refrigeration, air conditioning, etc. The company's operating segments include Titanium Technologies, Thermal & Specialized Solutions, and Advanced Performance Materials. It generates maximum revenue from the Titanium Technologies segment. The Titanium Technologies segment is a producer of TiO2 pigment, a premium white pigment used to deliver whiteness, brightness, opacity, durability, efficiency, and protection across a variety of applications. Geographically, the company derives a majority of its revenue from North America.